Hospice care for Medicare patients resulted in lower hospitalization rates and lower healthcare expenditures during the last year of life, according to a study published the November 12 issue of JAMA.
Hospice care for Medicare patients resulted in lower hospitalization rates and lower healthcare expenditures during the last year of life, according to a study published the November 12 issue of JAMA.
These same Medicare patients, with a poor
prognosis
cancer
, also had significantly lower rates of intensive care unit admissions and invasive procedures at the end of life. Ziad Obermeyer, MD, MPhil, of Brigham and Women’s Hospital and Harvard Medical School, and colleagues, used data from Medicare beneficiaries with poor prognosis cancer, such as brain, pancreatic, or metastatic malignancies.
The researchers matched those enrolled in hospice before death to those who died without hospice care. Of the 86,851 patients with poor-prognosis cancer, 60% entered hospice before death.
Nonhospice care beneficiaries had significantly greater healthcare utilization, largely for acute conditions not directly related to the cancer. Nonhospice care patients also had higher overall costs. Overall, costs during the last year of life were $62,819 for hospice beneficiaries and $71,517 for nonhospice beneficiaries.
“Our findings highlight the potential importance of frank discussions between physicians and patients about the realities of care at the end of life, an issue of particular importance as the Medicare administration weighs decisions around reimbursing physicians for advance care planning,” the authors wrote.
Compared with nonhospice beneficiaries, those patients who entered hospice care had lower rates of hospitalizations (65% vs 41%), intensive care unit admissions (36% vs 15%), invasive procedures (51% vs 27%), and death in a hospital or nursing facility (74% vs 14%).
In an accompanying editorial in JAMA, Joan M. Teno, MD, MS, and Pedro L. Gonzalo, PhD, of the Brown University School of Public Health, commented that valid measures of care quality are increasingly important as financial incentives change.
“Obermeyer and colleagues assessed hospitalization rates, intensive care admissions, and invasive procedures, but additional measures must have evidence of their ability to discriminate the quality of care and must be responsive to change, easy to understand, and actionable,” they wrote. “This will involve investing public dollars in the ‘quality’ of quality measures and their dissemination. If quality of care is not front and center, the momentum to improve end-of-life care in the United States could face a serious setback.”
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen